CDKN2A and prostate carcinoma: Not only do these data demonstrate a collaborative effect of AR expression and deletion of p16INK4a in promoting prostate cancer initiation and progression, but also provide a new and biological relevant mouse model that mimics the age-dependent human prostate cancer phenotypes.